Control normally costs a premium, so the direction of this discount is the part worth sitting with: 40% off, four billion dollars of paper valuation gone [9], applied in the one kind of transaction where the buyer usually pays up for the deciding vote. A valuation a company is chasing, though, is a valuation nobody has paid, so treating the lower figure as a markdown quietly assumes the higher one was real; the more useful version is that a control price would be the first number in 1X's history tested against a buyer who has to own the downside as well as the story.
Nothing in the reported terms says whether SoftBank's money is primary (new shares, cash into the company) or secondary (buying out people already on the register), and that distinction is close to the whole deal, because one funds the California line and the other funds the investors who funded it [1]. Spread $6bn across the first-year NEO line and each unit of annual capacity carries roughly $600,000 of valuation [18]; measure it against the end-2027 output target instead and the figure falls to about $60,000 [19]. Capacity is not shipments, and NEO is aimed at domestic use, where nobody has yet demonstrated a price [23].
What SoftBank buys mechanically is a business that started in Moss in 2014 as Halodi Robotics, building safe actuators and full-body control systems [21], plus a factory, plus a wheeled commercial android alongside the humanoid [23], and all of that folds into industrial robot arms the group has already agreed to own. This is probably wrong, but I read $6bn as a bet on actuators, control software and manufacturing that is being narrated as a bet on households.
The counter-thesis sits in SoftBank's own history. It sold Boston Dynamics to Hyundai at an estimated $325m [6], so $6bn is about 18 times the level at which this group last concluded that legged robots were worth exiting [20], and an investor capable of being wrong about legged robots in one direction is capable of being wrong in the other. What would break my read: a final print at or above the old ask, or a majority that turns out to be mostly primary capital earmarked to the 2027 output plan, either of which makes this growth financing rather than consolidation at a discount.
